Today, most people consume too much protein at dinner and not enough at breakfast. In recent years, scientific studies have shown that a balanced consumption of protein throughout the day […]

Legal The information on this site has been developed by Osteoporosis Canada in consultation with its Scientific Advisory Council. This Council is composed of leading Canadian medical and scientific experts […]

St. Michael’s Hospital celebrates the 20th anniversary of the establishment of FLS St. Michael’s Hospital celebrates the 20th anniversary of the establishment of FLS St. Michael’s Hospital (SMH) in Toronto […]

Osteoporosis Canada advises individuals on denosumab therapy to discuss their treatment with their physician prior to delaying therapy, stopping therapy or missing a scheduled dose.   Denosumab (Prolia) has been […]

A number of recent medical reports have linked high doses of intravenous bisphosphonates given to patients for the treatment of multiple myeloma, breast cancer or other cancers, to a condition […]

Denosumab (Prolia) has been shown to reduce the risk of fracture in postmenopausal women and men ≥50 years old with osteoporosis. It has also been approved for steroid induced bone […]

A number of recent medical reports have linked high doses of intravenous bisphosphonates given to patients for the treatment of multiple myeloma, breast cancer or other cancers, to a condition […]

If you are on medication for osteoporosis, are you ever tempted to stop taking it? If your answer is yes, you are not alone. Studies indicate that especially for those […]

Osteoporosis is a chronic condition that, if you are at high risk of fracture, requires treatment with an osteoporosis medication. There is currently no evidence that osteoporosis medications increase the […]